RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp expands COVID-19 clinical program, page-11

  1. 2,574 Posts.
    lightbulb Created with Sketch. 4962
    Fantastic announcement! Happy to see this come through this morning.. 40,000 daily cases in India of COVID-19 (is sad) . ResApp aiming to acquire data from 100 positive test subjects and 100 negative test subjects, should be the quick and easy goal when one considers the daily reported cases from India..

    Particularly what I like about this announcement is that it is focusing also on the management of this disease which will eventually see recurring ongoing revenue streams for ResApp. As the company has pointed out with the Delta strain this virus is here now to stay for the long haul regardless of the vaccination rates..

    In saying that though screening alone has massive potential just imagine the cost savings for both governments and community alike. With current testing taking between 24 to 72 hours just to receive your results after you've had your swab test to tell whether your clear or not. It's just ridiculous the way it is currently done lining up for hours just to receive the test as well.. there could be a much faster alternative and if we can prove this then this is going to be a huge game changer.. you can literally take the ResApp test and have your results produced instantly. No more waiting around for your results no more lining up in endless lines, no more lost productivity... the possibilities for this company and us as shareholders MASSIVE!!

    Cheers

    Red bar
    Last edited by Red bar: 09/08/21
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.